SARS-CoV-2 vaccine development: an overview and perspectives
Y Liu, K Wang, TF Massoud… - ACS Pharmacology & …, 2020 - ACS Publications
Coronavirus disease 2019, abbreviated as COVID-19, is caused by a new strain of
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It …
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It …
Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine
R Mirzaei, R Mohammadzadeh, F Mahdavi… - International …, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is a pandemic infectious disease caused by
the novel coronavirus called SARS-CoV-2. There is a gap in our understanding regarding …
the novel coronavirus called SARS-CoV-2. There is a gap in our understanding regarding …
[HTML][HTML] Progress and prospects on vaccine development against SARS-CoV-2
J Zhang, H Zeng, J Gu, H Li, L Zheng, Q Zou - Vaccines, 2020 - mdpi.com
In December 2019, the outbreak of pneumonia caused by a novel coronavirus, severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a serious pandemic in China …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a serious pandemic in China …
Review of current vaccine development strategies to prevent coronavirus disease 2019 (COVID-19)
BM Bennet, J Wolf, R Laureano… - Toxicologic …, 2020 - journals.sagepub.com
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) outbreak that started in
Wuhan, China, in 2019 resulted in a pandemic not seen for a century, and there is an urgent …
Wuhan, China, in 2019 resulted in a pandemic not seen for a century, and there is an urgent …
[HTML][HTML] A Review of the Progress and Challenges of Developing a Vaccine for COVID-19
A novel coronavirus, which has been designated as severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), was first detected in December 2019 in Wuhan China and …
coronavirus 2 (SARS-CoV-2), was first detected in December 2019 in Wuhan China and …
[PDF][PDF] SARS-CoV-2 vaccine development: Where are we
M Galdiero, M Galdiero, V Folliero… - Eur Rev Med …, 2021 - researchgate.net
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has proved to be one of the most challenging …
syndrome coronavirus 2 (SARS-CoV-2) has proved to be one of the most challenging …
[HTML][HTML] Platforms exploited for SARS-CoV-2 vaccine development
S Mathew, M Faheem, NA Hassain, FM Benslimane… - Vaccines, 2020 - mdpi.com
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the only
zoonotic-origin coronavirus (CoV) that has reached the pandemic stage. The virus uses its …
zoonotic-origin coronavirus (CoV) that has reached the pandemic stage. The virus uses its …
Potential SARS-CoV-2 vaccines: Concept, progress, and challenges
SA Hosseini, F Zahedipour, H Mirzaei… - International …, 2021 - Elsevier
Since September 2020, the world has had more than 28 million cases of coronavirus
disease 2019 (COVID-19). Many countries are facing a second wave of the COVID-19 …
disease 2019 (COVID-19). Many countries are facing a second wave of the COVID-19 …
[HTML][HTML] The race to a COVID-19 vaccine: Opportunities and challenges in development and distribution
RM Burgos, ME Badowski, E Drwiega… - Drugs in …, 2021 - ncbi.nlm.nih.gov
The unprecedented toll of severe acute respiratory syndrome coronavirus 2, the virus
responsible for coronavirus 2019 disease (COVID-19), jumpstarted the race towards the …
responsible for coronavirus 2019 disease (COVID-19), jumpstarted the race towards the …
[HTML][HTML] Potential therapeutic targets and vaccine development for SARS-CoV-2/COVID-19 pandemic management: a review on the recent update
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a highly pathogenic
novel virus that has caused a massive pandemic called coronavirus disease 2019 (COVID …
novel virus that has caused a massive pandemic called coronavirus disease 2019 (COVID …